>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
经血管介入栓塞治疗结核性大咯血的疗效分析
作者:胡春梅  方刚  唐晓军  黄莉莉  张侠 
单位:南京中医药大学附属南京医院/南京市第二医院 结核科, 江苏 南京 210036
关键词:支气管动脉 非支气管体循环动脉 肺动脉 介入栓塞治疗 结核 大咯血 
分类号:R521
出版年·卷·期(页码):2021·40·第六期(803-809)
摘要:

目的: 探讨肺结核患者大咯血时经血管介入栓塞治疗的疗效和预后情况。方法: 回顾性收集2018年7月至2020年7月期间因肺结核大咯血在南京市第二医院结核科住院, 经内科药物治疗1 d后仍反复咯血的患者, 行经支气管动脉、非支气管体循环动脉和肺动脉介入栓塞治疗, 统计分析其一般资料、肺部血管造影表现、栓塞治疗后疗效、复发情况和不良反应。结果: 62例患者中29例既往有肺结核病史(占46.8%), 4例为利福平耐药肺结核(占6.5%), 肺部空洞32例(占51.6%), 肺毁损12例(占19.4%); 26例合并糖尿病(占41.9%), 20例合并支气管扩张(占32.3%), 12例合并高血压(占19.4%), 2例合并慢性肺曲霉菌病(占3.2%)。肺部血管造影见62例患者都明确存在咯血责任血管, 包括支气管动脉、非支气管体循环动脉和肺动脉, 选择合适的栓塞材料进行超选择性栓塞。其中支气管动脉异常包括: 增粗7例(11.3%), 增多迂曲紊乱45例(72.6%), 支气管动脉-肺动脉瘘29例(46.8%), 支气管动脉-肺静脉瘘2例(3.2%), 支气管动脉交通支形成15例(24.2%), 支气管动脉与肋间动脉交通支5例(8.1%)。受累及的肺部非支气管体循环动脉异常包括: 肋间动脉19例(30.6%), 胸廓内动脉10例(16.1%), 膈下动脉3例(4.8%), 胸廓外动脉2例(3.2%), 腹腔干动脉1例(1.6%), 肾动脉1例(1.6%)。肺动脉分支形成假性肺动脉瘤4例(6.5%)。62例患者经血管介入栓塞治疗后, 62例达到即刻止血(100%), 54例(87.1%)治愈, 58例(93.5%)有效, 4例(6.5%)无效, 6例(9.7%)咯血复发。介入治疗无效和咯血复发的原因为形成新的出血动脉、栓塞血管再通以及肺动脉分支形成假性动脉瘤。经血管介入栓塞治疗后有部分患者出现轻度不良反应, 发热8例, 胸痛5例, 经对症治疗后都缓解恢复, 没有出现严重并发症。结论: 除常规支气管动脉异常外, 非支气管体循环动脉和肺动脉异常都可能参与肺结核性大咯血, 肺假性动脉瘤形成是介入栓塞治疗无效和复发的原因之一, 需要引起重视。结核大咯血经肺部血管介入栓塞治疗是一种安全、有效的治疗方法。

Objective: To discuss the effect and prognosis of vascular interventional embolization therapy for massive hemoptysis in tuberculosis patients.Methods: The patients, hospitalized in the tuberculosis department of the Second Hospital of Nanjing from July 2018 to July 2020 due to tuberculosis and massive hemoptysis, were retrospectively collected. They were treated with internal medicine for one day but remain hemoptysis, thus treated with interventional embolization of bronchial artery, non-bronchial circulation artery and pulmonary artery. The general data, pulmonary angiography, therapeutic effect after embolization, recurrence and adverse reactions were analyzed statistically.Results: Of the 62 patients, 29 patients(46.8%) had a previous history of tuberculosis, 4 cases (6.5%) were rifampicin-resistant tuberculosis, 32 patients(51.6%) had lung cavity and 12 cases(19.4%)had lung damage. Of all the 62 patients, 26(41.9%) had diabetes mellitus, 20(32.3%) had bronchiectasis, 12(19.4%) had hypertension, and 2(3.2%) had chronic pulmonary aspergillosis. Pulmonary angiography identified the culprit vessel for hemoptysis in 62 patients, including bronchial arteries, non-bronchial circulation arteries and pulmonary arteries. Therefore, appropriate embolization materials were selected to perform thesuperselective embolization. The bronchial artery abnormalities included artery enlargement(7/62, 11.3%), artery proliferation(45/62, 72.6%), artery fistula between bronchial artery and pulmonary(29/62, 46.8%), vein fistula between bronchial artery and pulmonary(2/62, 3.2%), bronchial artery traffic branch(15/62, 24.2%), traffic branch between bronchial artery and intercostal artery(5/62, 8.1%). The involved abnormal non-bronchial circulation arteries in pulmonary included intercostal artery(19/62, 30.6%), internal thoracic artery(10/62, 16.1%), inferior phrenic artery(3/62, 4.8%), external thoracic artery(2/62, 3.2%), trunk celiac artery(1/62, 1.6%), and renal artery(1/62, 1.6%). 4 patients(6.5%) were found with pseudo-pulmonary aneurysms in pulmonary artery branches. In all the patients, the cases of immediate hemostasis, cure, effective, ineffective, recurrence were 62(100%), 54(87.1%), 58(93.5%), 4(6.5%) and 6(9.7%). The main reasons for the failure of interventional therapy and recurrence of hemoptysis included the formation of new bleeding artery, the recanalization of embolized vessel and the rupture of pseudoaneurysm of pulmonary artery branch. After interventional embolization of all patients, some narrated mild adverse reactions, such as 8 cases had fever and 5 cases had chest pain, which were relieved and recovered after treatment, while no serious complications were observed.Conclusion: In addition to the abnormal bronchial arteries, abnormal non-bronchial circulation arteries and pulmonary arteries also participated in pulmonary massive hemoptysis especially, the formation of pulmonary pseudoaneurysm is one of the reasons responsible for the failure and recurrence of interventional embolization therapy. Pulmonary vascular embolization for massive tuberculosis hemoptysis is a safe and effective treatment.

参考文献:

[1] World Health Organization. Global tuberculosis report 2020[EB/OL]. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2020.
[2] SHIGEMURA N, WAN I Y, YU S, et al. Multidisciplinary management of life-threatening massive hemoptysis: a 10-year experience[J]. Ann Thorac Surg, 2009, 87(3): 849-853.
[3] 中华人民共和国国家卫生和计划生育委员会. WS 288-2017肺结核诊断[S]. 2017.
[4] 中国医师协会整合医学分会呼吸专业委员会. 大咯血诊疗规范[J]. 中华肺部疾病杂志(电子版), 2019, 12(1): 1-8.
[5] 吴先杰, 邢志珩, 田静, 等. 支气管动脉栓塞术治疗大咯血的疗效观察[J]. 中华结核和呼吸杂志, 2010, 33(10): 754-757.
[6] FRUCHTER O, SCHNEER S, RUSANOV V, et al. Bronchial artery embolization for massive hemoptysis: long-term follow-up[J]. Asian Cardiovasc Thorac Ann, 2015, 23(1): 55-60.
[7] 张守民, 李景英, 王国兴. 支气管动脉栓塞治疗肺结核咯血的疗效及复发原因分析[J]. 介入放射学杂志, 2012(5): 414-417.
[8] 雷红卫, 冯友银, 郑卫华, 等. 大咯血介入治疗术后复发原因与对策[J]. 放射学实践, 2014(2): 188-191.
[9] MONROE E J, PIERCE D B, INGRAHAM C R, et al. An interventionalist's guide to hemoptysis in cystic fibrosis[J]. Radiographics, 2018, 38(2): 624-641.
[10] KHALIL A, FARTOUKH M, BAZOT M, et al. Systemic arterial embolization in patients with hemoptysis: initial experience with ethylene vinyl alcohol copolymer in 15 cases[J]. AJR Am J Roentgenol 2010, 194(1): 104-110.
[11] 鲁仁财, 赵卫, 姜永能, 等. 肺部体循环动脉CTA在咯血介入治疗中的应用[J]. 中国介入影像与治疗学, 2016(13): 654-657.
[12] 李海泉. 选择性支气管动脉栓塞治疗肺结核咯血疗效分析[J]. 中国防痨杂志, 2008(3): 264-265.
[13] 王宾, 文宠佩, 王爱珠, 等. 介入栓塞治疗肺动脉假性动脉瘤伴大咯血的临床疗效分析[J]. 中华结核和呼吸杂志, 2020, 43(3): 223-227.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 413109 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364